Where is EVERSANA located?

EVERSANA is headquartered in Milwaukee, United States. It is registered at AP81, 7th Floor, Wing B, Koregaon Park, Annexe, Mundhwa, Pune - 411036, Pune, Pune, Maharashtra, India, 411036.

How many employees does EVERSANA have?

As of Jun 30, 2026, the latest employee count at EVERSANA is 4826.

Is EVERSANA a funded company?

EVERSANA is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does EVERSANA rank among its competitors?

EVERSANA ranks 3rd amongst 1079 active competitors, of which 71 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Caidya, which secured $165M in Jan, 2025.

Who are the top competitors of EVERSANA?

EVERSANA's top competitors include WuXi AppTec, ANI Pharmaceuticals and Ipsen. Among them, Caidya secured the most recent funding round in January, 2025.

EVERSANA - 2026 Company Profile, Team, Funding & Competitors

Company Details

Eversana offers consulting services for drug pricing access, reimbursement, adherence, and product delivery challenges. The services of the company include awareness programs, channel management, pharmacovigilance, quality assurance, global pricing, and regulatory support. Few groups of companies include The Acess Group, Alliance Life Sciences, Dohmen Life Science Services, Health Strategies Group, Medaccess, Triplefin, etc.

Website: eversana.com
Social
Phone Number: +1 **********
Registered Address: AP81, 7th Floor, Wing B, Koregaon Park, Annexe, Mundhwa, Pune - 411036, Pune, Pune, Maharashtra, India, 411036

Key Metrics

Founded Year

2014

Location

Milwaukee, United States

Stage

Funding Raised

Investors

North Sky Capital & 3 more

Ranked

3^rd among 1079 active competitors

Employee Count

4,826 as on Jun 30, 2026

Investment & Acquisitions

Waltz Health & 7 more

Similar Companies

WuXi AppTec & 1123 more

View EVERSANA's full profile

EVERSANA is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
EVERSANA LIFE SCIENCE SERVICES, LLC CIN: 7551168 , United States, Active	Aug 04, 2019	-	-	-
EVERSANA INDIA PRIVATE LIMITED CIN: U72200PN2009FTC142299 , India, Active	Feb 06, 2009	₹100 - ₹500 Cr (As on Mar 31, 2025)	940 (As on Dec 31, 2024)

EVERSANA is a funded company. EVERSANA has 4 institutional investors.

View details of EVERSANA's funding rounds and investors

EVERSANA's employee count trend

EVERSANA has 4,826 employees as of Jun 26. Here is EVERSANA's employee count trend over the years:

Uncover EVERSANA's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EVERSANA include WuXi AppTec, ANI Pharmaceuticals and Ipsen. Here is the list of Top 10 competitors of EVERSANA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
2nd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorgan Chase, Ampersand Capital & 4 others	64/100
3rd	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, ACE & Company & 2 others	63/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, Qualium Investissement ... & 2 others	63/100
5th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
6th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
7th	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	60/100
8th	Curatio healthcare 2005, Chennai (India), Acquired	Provider of market research services for biopharma sector, and dermatology products for cosmetologists	$44.8M	Camel Investment Limited, ChrysCapital & 13 others	59/100
9th	China Medical System 1992, Shenzhen (China), Public	Manufacturer of generic formulations	-	CMS Ventures	55/100
10th	Caidya 2003, Morrisville (United States), Series C	CRO focused on clinical development for phases II & III clinical trials and regulatory affair services	$373M	Qiming Venture Partners, LAV Asset Management ... & 22 others	54/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on EVERSANA's competitors? Click here to see the top ones

EVERSANA has not made any investments yet. EVERSANA has made 8 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Aug 26, 2025	Acquisition	Waltz Health	2021	Chicago (United States)
Oct 12, 2023	Acquisition	Healthware	2001	Salerno (Italy)
Dec 21, 2021	Acquisition	EVERSANA INTOUCH	2021	Kansas City (United States)